AKT1 and renal cell carcinoma: Since AKT up-regulation and loss of E-cadherin have previously been demonstrated in therapy-resistant RCC cells [60,61,62,63,64], it is conceivable that these proteins are also affected by ART in the sunitinib-resistant RCC cells.